Trade Alerts

Stocks

The Wall Street Journal: Sen. John McCain d...

Jul 19, 2017Comments off

WASHINGTON — Sen. John McCain (R., Ariz.), who has been out this week recovering from surgery, has been diagnosed with a type of brain cancer,

Better Buy: Micron Technology, Inc. vs. Qua...

Jul 19, 2017Comments off

Memory chipmaker Micron(NASDAQ:MU) outperformed mobile chipmaker Qualcomm(NASDAQ:QCOM) by a mile over the past 12 months. Micron rallied over 140% during that period, while Qualcomm gained just

How Tesla Makes Its Money: A Slicing and Di...

Jul 19, 2017Comments off

Tesla Inc. (NASDAQ:TSLA) stock is on the fast track this year. It’s gained 53.7% through July 18, versus the S&P 500‘s 11.1% return. This performance has

MarketWatch First Take: Qualcomm’s issues...

Jul 19, 2017Comments off

Qualcomm Inc.’s earnings were marred Wednesday by its complex legal fight with Apple Inc., but the communications chip designer has other issues as well. The

The 2 Biggest Challenges Facing Verizon Com...

Jul 19, 2017Comments off

After dominating the U.S. wireless market for much of the last decade, Verizon(NYSE:VZ) has fallen on hard times. Revenue and profits are down over the

The Wall Street Journal: U.S.-China economi...

Jul 19, 2017Comments off

WASHINGTON — High-level economic talks between the U.S. and China ended Wednesday without any progress, leaving the Trump administration’s efforts to recast trade ties with

MarketWatch First Take: IBM continues to pr...

Jul 18, 2017Comments off

IBM Corp., on the heels of its 21st consecutive quarter of declining revenue, is once again looking to the future for better news. IBM has

What Are Bear Funds?

Jul 18, 2017Comments off

Most investors focus on owning stocks with the expectation that they’ll rise in value. During bull markets, that strategy works very well. When bear markets

Does Puma Biotechnology's Approval Mak...

Jul 18, 2017Comments off

Puma Biotechnology‘s (NASDAQ:PBYI) roller-coaster ride to approval is finally over. After fits and starts in clinical trials, the FDA gave the company’s breast cancer drug, Nerlynx,

Intel Corporation May Have a "Gap"...

Jul 18, 2017Comments off

Former Intel (NASDAQ:INTC) executive Kirk Skaugen, who used to lead the company’s client computing group, admitted to making a serious mistake with respect to its